Literature DB >> 11303193

Quantification of immunoglobulins and cytokines in human cervical mucus during each trimester of pregnancy.

W H Kutteh1, R D Franklin.   

Abstract

OBJECTIVES: Our aims were to determine immunoglobulin and cytokine levels in cervical mucus obtained from women during each trimester of pregnancy and to compare these levels with those reported in normally menstruating women and in women taking oral contraceptives. STUDY
DESIGN: Cervical mucus samples were collected at specified intervals from 36 pregnant women. An enzyme-linked immunosorbent assay was used to quantitate the presence of immunoglobulins A and G and interleukins 1 beta, 6, and 10 in cervical mucus.
RESULTS: Immunoglobulin A in cervical mucus remained stable during each trimester of pregnancy (26 mg/dL). Cervical mucus immunoglobulin G decreased from a first-trimester high of 44.4 mg/dL to lower levels in the second and third trimesters. Levels of interleukin 1 beta increased significantly from the first trimester (4261 pg/mL) to 12,899 pg/mL in the second trimester (P <.01).
CONCLUSION: These data suggest a possible correlation of reproductive hormones and immunologic factors in the female reproductive tract during pregnancy.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11303193     DOI: 10.1067/mob.2001.113853

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  14 in total

1.  The impact of pregnancy on anti-HIV activity of cervicovaginal secretions.

Authors:  Brenna L Hughes; Riana Dutt; Christina Raker; Melody Barthelemy; Richard M Rossoll; Bharat Ramratnam; Charles R Wira; Susan Cu-Uvin
Journal:  Am J Obstet Gynecol       Date:  2016-07-05       Impact factor: 8.661

Review 2.  Guiding the vaginal microbicide trials with biomarkers of inflammation.

Authors:  Raina N Fichorova
Journal:  J Acquir Immune Defic Syndr       Date:  2004-10       Impact factor: 3.731

Review 3.  Clinical parameters essential to methodology and interpretation of mucosal responses.

Authors:  Brenna L Anderson; Susan Cu-Uvin
Journal:  Am J Reprod Immunol       Date:  2011-01-12       Impact factor: 3.886

4.  Repeated Measures of Cervicovaginal Cytokines during Healthy Pregnancy: Understanding "Normal" Inflammation to Inform Future Screening.

Authors:  Miatta A Buxton; Noemi Meraz-Cruz; Brisa N Sánchez; Betsy Foxman; Carina J Gronlund; Jorge Beltran-Montoya; Marisol Castillo-Castrejon; Marie S O'Neill; Felipe Vadillo-Ortega
Journal:  Am J Perinatol       Date:  2019-04-12       Impact factor: 1.862

Review 5.  Design of nanomaterials for applications in maternal/fetal medicine.

Authors:  N'Dea S Irvin-Choy; Katherine M Nelson; Jason P Gleghorn; Emily S Day
Journal:  J Mater Chem B       Date:  2020-05-26       Impact factor: 6.331

Review 6.  Targeted drug delivery for maternal and perinatal health: Challenges and opportunities.

Authors:  Anjali Sharma; Nirnath Sah; Sujatha Kannan; Rangaramanujam M Kannan
Journal:  Adv Drug Deliv Rev       Date:  2021-08-26       Impact factor: 17.873

7.  Cross-Sectional Analysis of Selected Genital Tract Immunological Markers and Molecular Vaginal Microbiota in Sub-Saharan African Women, with Relevance to HIV Risk and Prevention.

Authors:  Jordan K Kyongo; Tania Crucitti; Joris Menten; Liselotte Hardy; Piet Cools; Johan Michiels; Sinead Delany-Moretlwe; Mary Mwaura; Gilles Ndayisaba; Sarah Joseph; Raina Fichorova; Janneke van de Wijgert; Guido Vanham; Kevin K Ariën; Vicky Jespers
Journal:  Clin Vaccine Immunol       Date:  2015-03-11

8.  Pregnancy-induced changes in immune protection of the genital tract: defining normal.

Authors:  Brenna L Anderson; Hector Mendez-Figueroa; Joshua D Dahlke; Christina Raker; Sharon L Hillier; Susan Cu-Uvin
Journal:  Am J Obstet Gynecol       Date:  2013-01-10       Impact factor: 8.661

9.  Factors associated with fluctuations in IgA and IgG levels at the cervix during the menstrual cycle.

Authors:  Mahboobeh Safaeian; Roni T Falk; Ana Cecilia Rodriguez; Allan Hildesheim; Troy Kemp; Marcus Williams; Lidiana Morera; Manuel Barrantes; Rolando Herrero; Carolina Porras; Ligia Pinto
Journal:  J Infect Dis       Date:  2009-02-01       Impact factor: 5.226

10.  Influence of exogenous reproductive hormones on specific antibody production in genital secretions after vaginal vaccination with recombinant cholera toxin B subunit in humans.

Authors:  Lotta Wassen; Marianne Jertborn
Journal:  Clin Vaccine Immunol       Date:  2006-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.